Codagenix

Developer of live-attenuated viral vaccines using proprietary SAVE technology

placeStony Brook, New York, United States calendar_todayFounded 2011 groups41 employees language codagenix.com

Registered entities

Investor mix

11 investors on record; lead investors include Adjuvant Capital, Topspin Fund, Euclidean Capital, Serum Institute of India.

Investor typeCountShare
Venture capital436%
Angel & family office19%
Other / undisclosed655%
Coming soon